Companies:
49,638
Total Market Cap:
134075337934734.49
Global Rank
#1699
Country Rank
#206
Market Cap
11.39 B
Price
0.625
Change (%)
1.80%
Volume
15.24 M
Sino Biopharmaceutical Limited's latest marketcap:
11.39 B
As of 06/18/2025, Sino Biopharmaceutical Limited's market capitalization has reached $11.39 B. According to our data, Sino Biopharmaceutical Limited is the 1699th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 11.39 B |
| Revenue (ttm) | 3.91 B |
| Net Income (ttm) | 474.27 M |
| Shares Out | 17.88 B |
| EPS (ttm) | 0.03 |
| Forward PE | 25.94 |
| Ex-Dividend Date | 06/16/2025 |
| Earnings Date | 08/25/2025 |
Market Cap Chart
Data Updated: 06/18/2025
Sino Biopharmaceutical Limited's yearly market capitalization.
Sino Biopharmaceutical Limited has seen its market value drop from HK$34.74 B to HK$11.39 B since 2014, representing a total decrease of 67.22% and an annual compound decline rate (CAGR) of 10.11%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/18/2025 | HK$11.39 B | 53.5% | 1699 |
| 12/31/2024 | HK$58.26 B | -8.75% | 2186 |
| 12/29/2023 | HK$63.85 B | -24.41% | 1928 |
| 12/30/2022 | HK$84.46 B | -17.53% | 1420 |
| 12/31/2021 | HK$102.41 B | -27.33% | 1444 |
| 12/31/2020 | HK$140.92 B | 3.1% | 964 |
| 12/31/2019 | HK$136.69 B | 110.43% | 809 |
| 12/31/2018 | HK$64.96 B | -36.77% | 1348 |
| 12/29/2017 | HK$102.73 B | 153.85% | 991 |
| 12/30/2016 | HK$40.47 B | -22.66% | 1853 |
Company Profile
About Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited is an investment holding company that operates as a research and development pharmaceutical conglomerate in the People’s Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
Business Segments
- Modernised Chinese Medicines and Chemical Medicines
- Investment
- Others
Product Portfolio
- Oncology Medicines: Anlotinib hydrochloride capsules (Focus V), Penpulimab injection (Annike), Efbemalenograstin alfa injection (Yilishu), Pomalidomide capsules (Anyue), Bevacizumab injection (Anbeisi), Rituximab injection (Delituo), Trastuzumab for injection (Saituo).
- Liver Disease Medications: Magnesium isoglycyrrhizinate injection (Tianqing Ganmei), Entecavir dispersible tablets (Runzhong).
- Respiratory System Medicines: Budesonide suspension for inhalation (Tianqing Suchang), Colistimethate sodium for injection (Tianyun).
- Surgery/Analgesia Medicines: Flurbiprofen cataplasms (Zepolas), Limaprost tablets (Kailitong), Recombinant human coagulation factor VIII for injection (Anhengji).
- Cardio-Cerebral Vascular Medicines: Irbesartan and hydrochlorothiazide tablets (Yilunping), Beraprost sodium tablets (Kaina).
- Biosimilar Medicines: Adalimumab solution for injection (Taibowei).
Drug Development Pipeline
- Oncology Drugs: Benmelstobart, D-1553, TQ-B3139, TQ-B3101.
- Liver Disease Drugs: Lanifibranor, TQA2225/AP025.
- Respiratory System Drugs: TDI01, TQC2731, TCR1672, TQC3721, TQH2722.
- Surgery/Analgesia Drugs: PL-5 (antimicrobial peptide).
Additional Operations
The company is also involved in long-term investments and operates in the healthcare and hospital business sectors.
Frequently Asked Questions
-
What is Sino Biopharmaceutical Limited's (HKG-1177) current market cap?As of 06/18/2025, Sino Biopharmaceutical Limited (including the parent company, if applicable) has an estimated market capitalization of $11.39 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Sino Biopharmaceutical Limited (HKG-1177) rank globally by market cap?Sino Biopharmaceutical Limited global market capitalization ranking is approximately 1699 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.